Nasdaq
$0.7206▲ 0.10%vs prev close
🔒 Quotes & buy pressure are MAX onlySee plans
Market cap $71.5MShares out 99.3M sh
Chart
Filings & news by date
Hover (PC) or tap (mobile) a candle to see that day only
Filings
7- 10.8Pre-market26.10.08 20:408-KKey event#●●●#●●●#●●●
Hyperfine, Inc.Bullish
Hyperfine, Inc. reported preliminary third-quarter 2026 revenue of approximately $6.0 million, representing a 53% sequential growth. The company expects cash and cash equivalents to be approximately $37.9 million as of September 30, 2026, and reaffirmed its full-year 2026 revenue guidance of $20 million to $22 million.…more
$0.7206+0.10%vs prev closeDetected5m · 30m · 60m · Next dayPLUSView filingShare
- 9.18After-hours26.09.19 05:078-KKey event
Hyperfine, Inc.
Hyperfine, Inc. received a notice from Nasdaq indicating that it no longer meets the minimum bid price requirement of $1.00 per share, as its stock has traded below this threshold for 30 consecutive business days. The company has been granted an initial 180-day compliance period, ending March 16, 2027, to regain compliance by maintaining a closing bid price of at least $1.00 for 10 consecutive business days.…more
$0.7206+0.10%vs prev closeView filingShare - 8.25After-hours26.08.26 05:154Ownership
Hyperfine, Inc.
Hyperfine, Inc. insider Thomas Teisseyre filed a Form 4 on August 25, 2026, reporting a change in beneficial ownership of securities as of August 24, 2026. This filing serves as an official record of the insider's equity transaction and reflects the current status of internal holdings.…more
$0.7206+0.10%vs prev closeView filingShare
6 more filings
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report
News
GlobeNewswire- 10.8Pre-market26.10.08 20:32Bullish#●●●#●●●
Hyperfine Reports Preliminary Q3 Revenue of $6M, Up 53% Sequentially
Hyperfine reported preliminary Q3 revenue of approximately $6 million, marking a 53% increase from the previous quarter. Additionally, the company's net cash burn decreased by 29% during the same period.…more
$0.7206+0.10%vs prev closeDetected5m · 30m · 60m · Next dayPLUSShareBenzinga
- 9.15Pre-market26.09.15 21:16
●●●●●●●● ●●●●● ●●●●●●
Hyperfine has completed patient enrollment for its Contrast PMR study of the Swoop portable MRI system. The company plans to submit an FDA 510(k) application by the end of 2026 to expand the device's clinical indications.…more
$0.7206+0.10%vs prev closeShareBenzinga - 8.26Pre-market26.08.26 21:18
●●●●●●●● ●●●●● ●●●●●●
Hyperfine's portable MRI system, Swoop, demonstrated high clinical concordance with high-field MRI in a peer-reviewed study published in the Journal of Neuroimaging. The study also highlighted strong patient preference for the portable system, supporting its growing adoption in neurology practices.…more
$0.7206+0.10%vs prev closeShareBenzinga
2 more news items
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report